scispace - formally typeset
A

Andrew M. Riley

Researcher at University of Oxford

Publications -  95
Citations -  2504

Andrew M. Riley is an academic researcher from University of Oxford. The author has contributed to research in topics: Inositol & Phosphatidylinositol. The author has an hindex of 26, co-authored 90 publications receiving 2294 citations. Previous affiliations of Andrew M. Riley include University of Bath.

Papers
More filters
Journal ArticleDOI

Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.

TL;DR: In this paper, the crystal structures of the wild-type PH domain and a gain-of-function mutant E41K in complex with D-myo -inositol 1,3,4,5-tetra-kisphosphate (Ins (1, 3, 4,5)P 4 ) were determined.
Journal ArticleDOI

Identification of mammalian Vps24p as an effector of phosphatidylinositol 3,5-bisphosphate-dependent endosome compartmentalization.

TL;DR: The use of cDNA phage libraries in conjunction with synthetic biotinylated derivatives of phosphatidylinositol 3,5-bisphosphate in the identification of a mammalian phosphate-binding protein, mVps24p, is reported, providing the first direct link between phosphate-based lipid found in eukaryotes and the protein machinery involved in the production of the class-E cellular phenotype.
Journal ArticleDOI

Insights into the activation mechanism of class I HDAC complexes by inositol phosphates.

TL;DR: The stereochemical requirements for binding and activation by inositol phosphates are elucidated, demonstrating that activation requires three adjacent phosphate groups and that other positions on the inositl ring can tolerate bulky substituents.
Journal ArticleDOI

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.

TL;DR: It is shown that FGF-2 induces Akt phosphorylation in HUVEC resulting in antiapoptotic effect in serum-deprived cells and increase in cellular motility, which definitively identify the Akt inhibitor Ins(1,3,4,5,6)P5 as a specific antiangiogenic and antitumor factor.
Journal ArticleDOI

Determination of neo- and D-chiro-inositol hexakisphosphate in soils by solution 31P NMR spectroscopy.

TL;DR: Reappraisal of the literature based on the new signal assignments revealed that neo- and d-chiro-IP6 occur widely in both terrestrial and aquatic ecosystems, and confirmed that the inositol phosphates can constitute a considerable fraction of the organic phosphorus in soils.